Experience

    • Pantheon and LGT Capital Partners as lead investors in a continuation vehicle sponsored by Medicxi, a European life sciences investor, involving six preclinical- and clinical-stage assets.
    • HarbourVest Partners and Pantheon as investors in 3i’s GP-led single asset fund restructuring, one of the largest-ever such transactions which involved moving Action, with a post-discount enterprise value of €10.25 billion, to a continuation vehicle.
    • LeapFrog Investments in the formation of LeapFrog Financial Inclusion Fund III, a $700 million emerging markets-focused impact fund.